PPT-Management of Clostridium Difficile Infection

UC Irvine Medical Center Department of Internal Medicine 052018 Mitch Edwards DO Objectives Define the severity of Clostridium Difficile Infection CDI Learn how to treat CDI by degree of severity. (CDI). . Infections Toolkit. . Activity C: ELC Prevention Collaboratives. Draft - 12/23/09 --- Disclaimer: The findings and conclusions in this presentation are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.. (CDI). . Infections Toolkit. . Activity C: ELC Prevention Collaboratives. Last reviewed . - . 2/29/12 . --- Disclaimer: The findings and conclusions in this presentation are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.. . Infections Toolkit. . Activity C: ELC Prevention Collaboratives. Last reviewed . - . 2/29/12 . --- Disclaimer: The findings and conclusions in this presentation are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.. Last reviewed 03/04/2016. . Disclaimer. : The findings and conclusions in this presentation are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.. Kevin W. Garey, PharmD. , MS, FASHP. Professor and Chair. Department . of Pharmacy Practice and Translational Research. Update on progress of city-wide stewardship projects. Focus on a better understanding of antimicrobial resistance in the Houston area. UC Irvine Medical Center. Department of Internal Medicine. 05/2018. Mitch Edwards, D.O.. Objectives. Define the severity of Clostridium Difficile Infection (CDI). Learn how to treat CDI by degree of severity. Kevin W. Garey, PharmD. , MS, FASHP. Professor and Chair. Department . of Pharmacy Practice and Translational Research. Update on progress of city-wide stewardship projects. Focus on a better understanding of antimicrobial resistance in the Houston area. OHA HEN 2.0. C. Difficile Infection (CDI). AIM. Primary Drivers. Secondary Drivers. Change Ideas. Reduce CDI by 40%. Antimicrobial Stewardship. Audit antimicrobial use prospectively and provide direct feedback to the provider. Infection. Serin. a Tart, PharmD. Antimicrobial Stewardshi. p Coordinator Clinical Pharmacist. Cape Fear Valley Health. start@capefearvalley.com. . I have no relevant financial relationships with the manufacturers of any of the products discussed in this CE activity. Chapter 13: Updated:  Potential Food Safety Hazard  Control Measures  FDA Guideline  Growth  Heat Resistance  Analytical Procedures o Food sampling and preparation of sample homoge Jhung MA, Thompson AD, Killgore GE, Zukowski WE, Songer G, Warny M, et al. Toxinotype V Clostridium difficile in Humans and Food Animals. Emerg Infect Dis. 2008;14(7):1039-1045. https://doi.org/10.3201/eid1407.071641. Levy P, Fournier P, Lotte L, Million M, Brouqui P, Raoult D. Clostridium tetani Osteitis without Tetanus. Emerg Infect Dis. 2014;20(9):1571-1573. https://doi.org/10.3201/eid2009.131579. updated. . Clostridium . Difficile. Prevention Primer . is available . at . http://. www.cdc.gov/hai/pdfs/toolkits/CDI-Primer-2-2016.pdf. Clostridioides. Difficile. Infection. Levi Teigen, PhD, RD. May 11, 2021. Objectives. Recognize the nutritional implications of a . C. difficile . infection at both a systemic and local (i.e. colonic) level.